The Weekly Litigation News Digest is now live. Subscribe now

Thomann competitive analysis

Loading summary...

Explore patent oppositions filed by Thomann against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 13, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Pegylated Liposomes For Delivery Of Immunogen-Encoding RnaGLAXOSMITHKLINESep 28, 2023
Pegylated Liposomes For Delivery Of Immunogen-Encoding RnaGLAXOSMITHKLINESep 21, 2023
Pegylated Liposomes For Delivery Of Immunogen-Encoding RnaGLAXOSMITHKLINESep 6, 2023
Virion-Like Delivery Particles For Self-Replicating Rna MoleculesGLAXOSMITHKLINEJul 11, 2023
Pegylated Liposomes For Delivery Of Immunogen-Encoding RnaGLAXOSMITHKLINEFeb 21, 2023
Pegylated Liposomes For Delivery Of Immunogen-Encoding RnaGLAXOSMITHKLINEFeb 21, 2023
Pegylated Liposomes For Delivery Of Immunogen-Encoding RnaGLAXOSMITHKLINEDec 9, 2022
Immunoactivating Antigen-Binding MoleculeCHUGAI SEIYAKU KABUSHIKI KAISHAJul 13, 2022

Latest PTAB cases involving Thomann

Discover the latest PTAB cases involving Thomann, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Thomann with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
THOMANN8 - - -
CHUGAI SEIYAKU KABUSHIKI KAISHA378 - 1
GLAXOSMITHKLINE29112812
NOVARTIS6422 - 21